TRASIS SA

Overview

TRASIS SA is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering [18F]MK6240 ON THE TRASIS ALLINONE SYNTHESIZER; THE SYNTHESIS OF [18F]FDG QUAD/DUAL+ ON TRASIS ALLINONE SYNTHESIZER; THE SYNTHESIS PATHWAY OF [18F]DCFPYL ON THE TRASIS ALLINONE SYNTHESIZER; THE SYNTHESIS PATHWAY OF [18F]FDOPA.

API / Drug Master Files

TRASIS SA holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• THE SYNTHESIS OF [18F]FDG QUAD/DUAL+ ON TRASIS ALLINONE SYNTHESIZERActive2026-01-20
• [18F]MK6240 ON THE TRASIS ALLINONE SYNTHESIZERActive2025-06-03
• THE SYNTHESIS PATHWAY OF [18F]FDOPAActive2021-07-12
• THE SYNTHESIS PATHWAY OF [18F]DCFPYL ON THE TRASIS ALLINONE SYNTHESIZERActive2020-05-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TRASIS SA in our records. PharmaTek screens the full directory against live FDA enforcement data.